Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Dec 28, 2025

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
Published on: June 29, 2022
Youssef Jalloul1, Marwan M Refaat1
1Division of Cardiology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
No abstract available in PubMed .